ECO Animal Health Group plc (FRA:LWA)

Market Cap	69.49M +41.8%
Revenue (ttm)	98.31M +1.4%
Net Income	3.46M +359.0%
EPS	0.05 +352.1%
Shares Out	n/a
PE Ratio	20.08
Forward PE	21.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.9650
Previous Close	0.9750
Day's Range	0.9650 - 0.9750
52-Week Range	0.7550 - 1.4100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 10, 2026

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infectio...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 200
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LWA

Financial Performance

In fiscal year 2025, ECO Animal Health Group's revenue was 79.60 million, a decrease of -10.99% compared to the previous year's 89.42 million. Earnings were 1.69 million, an increase of 60.88%.

Financial numbers in GBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error